Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | AGXT | P21549 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 5/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.43 |
| ▸ | TACR1 | P25103 | 5/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.37 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.36 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.36 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7964945 | 1.00 | IDO1 (0.48) | IDO1AGXTMAOBLOXL2TACR1 | |
| SCHEMBL6977485 | 0.84 | IDO1 (0.47) | IDO1AGXTMAOBLOXL2TACR1 | |
| SCHEMBL5025103 | 0.83 | IDO1 (0.43) | IDO1AGXTMAOBLOXL2TACR1 | |
| SCHEMBL2781643 | 0.82 | TACR1 (0.59) | IDO1AGXTTACR1SLC1A1 | |
| SCHEMBL7965700 | 0.82 | TACR1 (0.59) | IDO1AGXTTACR1SLC1A1 | |
| SCHEMBL7967707 | 0.82 | TACR1 (0.59) | IDO1AGXTTACR1SLC1A1 | |
| Hydrochloric Acid SCHEMBL6983593 | 0.82 | IDO1 (0.48) | IDO1AGXTMAOBLOXL2TACR1 | |
| SCHEMBL7971279 | 0.81 | IDO1 (0.48) | IDO1MAOBTACR1TAAR1SLC1A1 | |
| SCHEMBL7968337 | 0.81 | CHRNB2 (0.50) | IDO1AGXTMAOBTACR1 | |
| SCHEMBL7964719 | 0.81 | IDO1 (0.48) | IDO1MAOBTACR1TAAR1SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6274715-B1 | SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY | ABBOTT LABORATORIES | 2001-08-14 | — | — | US | disclosed |
| EP-0961776-A1 | TRICYCLIC ERYTHROMYCIN DERIVATIVES | Abbott Laboratories (US) | 1999-12-08 | — | — | EP | disclosed |
| WO-1998030574-A1 | TRICYCLIC ERYTHROMYCIN DERIVATIVES | ABBOTT LABORATORIES (US) | 1998-07-16 | — | — | WO | disclosed |